CARLOS JESUS
DUEÑAS GUTIERREZ
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (8)
2023
-
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic
Viruses, Vol. 15, Núm. 2
-
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
Viruses, Vol. 15, Núm. 4
2022
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
2021
-
Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can
Frontiers in Immunology, Vol. 12
-
Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality
Mediators of Inflammation, Vol. 2021
-
Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection
Journal of Personalized Medicine, Vol. 11, Núm. 7
-
HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients
Journal of Clinical Medicine, Vol. 10, Núm. 9
2007
-
Impacto de la reducción de dosis de estavudina en su perfil de eficacia/seguridad en pacientes con infección por el virus de la inmunodeficiencia humana inmunológica y virológicamente estables
Medicina Clinica, Vol. 129, Núm. 10, pp. 361-365